South Africa on Sunday said it would suspend its rollout of the Oxford-AstraZeneca vaccine after initial trials showed “disappointing” results against the B.1.351 variant of COVID-19.
The country has received 1 million doses of the jab. It had planned to start using it to vaccinate frontline healthcare workers from mid-February.
The study, involving around 2,000 people, found the vaccine offered “minimal protection” against mild and moderate cases of COVID-19. It has not yet been peer-reviewed.
Er wordt gespeeld met de gedachte dat er een RevoTV Soemo zal komen met zendtijd in heel Suriname. Hier wordt aan gewerkt… meneer Soemo.